Publications by authors named "Sebastian Gulde"

Claim this Profile
S
Simultaneous magnetic resonance imaging of pH, perfusion and renal filtration using hyperpolarized C-labelled Z-OMPD.
Martin Grashei, Pascal Wodtke, Jason G Skinner, Sandra Sühnel, Nadine Setzer, Sebastian Gulde

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas.
Daniela Modena, Maria Luisa Moras, Giovanni Sandrone, Andrea Stevenazzi, Barbara Vergani, Sebastian Gulde

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inceptor correlates with markers of prostate cancer progression and modulates insulin/IGF1 signaling and cancer cell migration.
Katharina Wissmiller, Sara Bilekova, Andras Franko, Stefan Z Lutz, Miriam Katsburg, Sebastian Gulde

Mol Metab· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects.
Sebastian Gulde, Alessia Foscarini, Simon L April-Monn, Edoardo Genio, Alessandro Marangelo

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angpt2/Tie2 autostimulatory loop controls tumorigenesis.
Ninelia Minaskan Karabid, Tobias Wiedemann, Sebastian Gulde, Hermine Mohr, Renu Chandra Segaran

EMBO Mol Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
Katharina Wang, Ina Schütze, Sebastian Gulde, Nicole Bechmann, Susan Richter

Endocr Relat Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors.
Sebastian Gulde, Tobias Wiedemann, Mathias Schillmaier, Isabel Valença, Amelie Lupp

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development.
Hermine Mohr, Simone Ballke, Nicole Bechmann, Sebastian Gulde, Jaber Malekzadeh-Najafabadi

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
Eva-Maria Bogner, Adrian F Daly, Sebastian Gulde, Auli Karhu, Martin Irmler

Int J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis